July 30, 2009
Based in Palo Alto, California, one of the leading vc firms, which invests prominently in the medical industry, Skyline Ventures announced today that it has named Glenn Reicin as the vc firm’s new managing director. Glenn Reicin has been with Skyline Ventures since October 2008, where he held a position as a venture partner. Along with the promotion of Glenn Reicin as managing director of the vc firm, Skyline Ventures also announced the addition of other people who are joining its team. These people, who are joining the Skyline team, include Dr. Leon E. Chen, PhD and Kristin Lynn Myers; who will be joining Skyline Ventures as full-time associates. Also joining Skyline Ventures’ investment team are Dr. John G. Freund, MD; Dr. Eric M. Gordon, PhD; Dr. Stephan J. Hoffman, MD and PhD; Dr. Yasenuri Kaneko, MD; Dr. David G. Lowe, PhD; and Dr. Stephan J. Sullivan, MD.
Before coming to Skyline Ventures, Mr. Reicin worked at Morgan Stanley, where he held the position of managing director at Morgan Stanley’s research department. The main focus of Mr. Reicin’s job at Morgan Stanley’s research department was to research medical devices and supplies. Mr. Reicin was also ranked in the Institutional Investor as an All-America team from 1994 to 2008. Mr. Reicin also worked at Oppenheimer & Company, Inc., where he was Senior Vice President.
Founded in 1997, Skyline Ventures is a vc firm that has become well known as an investor in healthcare companies in all stages of their life. Skyline Ventures currently has roughly $800 million under its management and primarily invests $15 million to $30 million per investment round. Some companies in Skyline’s portfolio include AcelRx Pharmaceuticals, Advion, Arca Biopharma, Calibra Medical, Discoverx, and others.
For more information about Skyline Ventures, click here.